Clincosm LogoSign in Get a demo

chondrosarcoma

Showing 1 - 25 of 32
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Chordoma, Chondrosarcoma, Ewing Sarcoma Trial in Nice (Proteus ONE one daily beam, Proteus ONE two daily beam)

Recruiting
  • Chordoma
  • +3 more
  • Proteus ONE one daily beam
  • Proteus ONE two daily beam
  • Nice, France
    Centre Antoine lacassagne
Sep 14, 2023

Engagement Trends in Chondrosarcoma Clinical Trials

Not yet recruiting
  • Chondrosarcoma
    • San Francisco, California
      Power Life Sciences
    Sep 1, 2023

    Chordoma, Chondrosarcoma Trial in Madrid (5-fraction hipofractionated protontheray)

    Recruiting
    • Chordoma
    • Chondrosarcoma
    • 5-fraction hipofractionated protontheray
    • Madrid, Spain
      Centro de Protonterapia Quironsalud
    May 15, 2023

    Personalized Home Exercise Program in Bone Tumor Undergoing

    Recruiting
    • Osteosarcoma
    • +3 more
      • Bologna, Italy
        Istituto Ortopedico Rizzoli
      Mar 21, 2023

      Solid Tumor, Colorectal Cancer, Gastric Cancer Trial in United States (IGM-8444, FOLFIRI, Bevacizumab (and approved

      Recruiting
      • Solid Tumor
      • +7 more
      • Duarte, California
      • +11 more
      Jan 6, 2023

      Adenocarcinoma, Adenocystic Carcinoma, Anal Cancer Trial in Idaho Falls (diagnostic test, drug, other)

      Recruiting
      • Adenocarcinoma
      • +75 more
      • Biomarker Testing (L)
      • +2 more
      • Idaho Falls, Idaho
      • +1 more
      Oct 18, 2022

      Epithelioid Sarcoma (Ex-US Only), Spindle Cell Sarcoma, Sinonasal Carcinoma Trial (Tazemetostat)

      Temporarily not available
      • Epithelioid Sarcoma (Ex-US Only)
      • +19 more
      • (no location specified)
      Oct 17, 2022

      Pediatric Cancer, Hodgkin Disease, CD30-Positive DLBCL Trial in Milwaukee (anti-CD30 Bispecific Antibody-armed

      Not yet recruiting
      • Pediatric Cancer
      • +11 more
      • anti-CD30 Bispecific Antibody-armed anti-CD3-Activated Autologous T-cells (CD30 biAb-AATC)
      • Milwaukee, Wisconsin
        Children's Wisconsin
      Sep 14, 2022

      Chondrosarcoma Trial in Houston (Proton Beam Therapy)

      Active, not recruiting
      • Chondrosarcoma
      • Proton Beam Therapy
      • Houston, Texas
        MD Anderson Cancer Center
      Aug 25, 2022

      Bone Sarcoma, Osteosarcoma, Ewing Sarcoma Trial in France (Treatment by Regorafenib, Treatment by Placebo)

      Recruiting
      • Bone Sarcoma
      • +6 more
      • Treatment by Regorafenib
      • Treatment by Placebo
      • Besançon, France
      • +15 more
      Aug 18, 2022

      Image Assisted Optimization of Proton Radiation Therapy in

      Recruiting
      • Bone Neoplasm of Vertebral Column
      • +5 more
        • Delft, South Holland, Netherlands
        • +1 more
        Apr 5, 2022

        Chondrosarcoma, Osteosarcoma, Soft Tissue Sarcoma Trial in United States (Abemaciclib)

        Recruiting
        • Chondrosarcoma
        • +2 more
        • Jacksonville, Florida
        • +3 more
        Apr 4, 2022

        Chondrosarcoma Trial in Iowa City (Zoledronic Acid)

        Recruiting
        • Chondrosarcoma
        • Zoledronic Acid
        • Iowa City, Iowa
          University of Iowa Hospitals and Clinics
        Mar 16, 2022

        Pancreatic Cancer, Osteosarcoma, MPNST (Malignant Peripheral Nerve Sheath Tumor) Trial in Santa Monica (DeltaRex-G)

        Available
        • Pancreatic Cancer
        • +6 more
        • Santa Monica, California
          Sarcoma Oncology Research Center, LLC
        Jan 20, 2022

        Chondrosarcoma Trial (Anlotinib HCl, PD-1 inhibitor)

        Not yet recruiting
        • Chondrosarcoma
        • Anlotinib hydrochloride
        • PD-1 inhibitor
        • (no location specified)
        Dec 31, 2021

        Advanced Endometrial Carcinoma, Advanced Head and Neck Squamous Cell Carcinoma, Advanced Malignant Solid Tumor Trial in Houston

        Recruiting
        • Advanced Endometrial Carcinoma
        • +36 more
        • Glutaminase Inhibitor IPN60090
        • Pembrolizumab
        • Houston, Texas
          M D Anderson Cancer Center
        Sep 9, 2021

        Long-Term Longitudinal QoL in Patients Undergoing EEA

        Recruiting
        • Pituitary Tumor
        • +7 more
          • Columbus, Ohio
            Ohio State University
          Jun 20, 2021

          Chondrosarcoma, Metastatic Chondrosarcoma Trial in United Kingdom, United States (pazopanib)

          Completed
          Has Results
          • Chondrosarcoma
          • Metastatic Chondrosarcoma
          • Duarte, California
          • +6 more
          Feb 10, 2020

          Glioma, Cholangiocarcinoma, Chondrosarcoma Trial in Amsterdam, Leiden (Metformin and chloroquine combination)

          Completed
          • Glioma
          • +2 more
          • Metformin and chloroquine combination
          • Amsterdam, Noord-Holland, Netherlands
          • +2 more
          Jan 7, 2020

          Bone Cancer, Chondrosarcoma, Ewing's Sarcoma Trial in Stanford (Feraheme, Magnetic Resonance Imaging (MRI) scan)

          Completed
          Has Results
          • Bone Cancer
          • +7 more
          • Feraheme
          • Magnetic Resonance Imaging (MRI) scan
          • Stanford, California
            Stanford University School of Medicine
          May 30, 2019

          Carney Complex, Chondrosarcoma, Gastrointestinal Stromal Tumor Trial in United States (Laboratory Biomarker Analysis,

          Completed
          Has Results
          • Carney Complex
          • +3 more
          • Laboratory Biomarker Analysis
          • +2 more
          • Palo Alto, California
          • +7 more
          Aug 23, 2018

          Bone Cancer, Chondrosarcoma, Clear Cell Sarcoma of the Kidney Trial in Winston-Salem (therapeutic angiotensin-(1-7), laboratory

          Completed
          Has Results
          • Bone Cancer
          • +11 more
          • therapeutic angiotensin-(1-7)
          • laboratory biomarker analysis
          • Winston-Salem, North Carolina
            Wake Forest University Health Sciences
          Jul 2, 2018

          Soft Tissue Sarcoma, Bone Sarcoma, Chondrosarcoma Trial (Ipilimumab, Nivolumab)

          Unknown status
          • Soft Tissue Sarcoma
          • +7 more
          • (no location specified)
          Oct 30, 2017

          Chondrosarcoma Trial in France (Everolimus 2.5 mg/day, Everolimus 10 mg/day)

          Suspended
          • Chondrosarcoma
          • Everolimus 2.5 mg/day
          • Everolimus 10 mg/day
          • Bordeaux, Gironde, France
          • +11 more
          Aug 4, 2017

          Chordoma, Chondrosarcoma Trial in Boston (Charged Particle Radiation Therapy)

          Completed
          • Chordoma
          • Chondrosarcoma
          • Charged Particle Radiation Therapy
          • Boston, Massachusetts
            Massachusetts General Hospital
          Jun 14, 2017